Supporting Informed Decision Making About Multi-cancer Early Detection Testing

Launched by M.D. ANDERSON CANCER CENTER · Mar 10, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on creating a new educational tool to help people make informed decisions about Multi-Cancer Early Detection (MCED) tests, which are new blood tests designed to screen for multiple types of cancer. The goal is to provide clear information so participants can understand what these tests are and how they may benefit them in early cancer detection.

To participate, individuals should be between the ages of 65 and 74 and must not have a history of cancer, except for certain types of non-aggressive skin cancer. During the trial, participants will receive guidance and support from the research team, along with the educational aid being developed. It's important to note that the trial is currently recruiting participants, and those who are eligible will be helped through the process by the study staff. This is a great opportunity for eligible individuals to contribute to research that could improve cancer screening in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • • Recruitment and eligibility will be assessed by CCETR.CCETR staff will help distribute recruitment flyers, assess subject eligibility, and refer eligible subjects to the research team (Appendix B, C \& I).
• Exclusion Criteria:
• • • History of cancer other than basil cell and squamous cell skin cancer, per self-report.